Compare Hims and Hers Health Inc (HIMS) vs Nasdaq Inc (NDAQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Nasdaq Inc — how do they compare? Hims and Hers Health Inc trades at $32.95 (market cap $7.57B), while Nasdaq Inc trades at $90.27 (market cap $51.96B). The key difference: Nasdaq Inc is far larger — about 6.9× Hims and Hers Health Inc's market cap, and Nasdaq Inc pays a 1.22% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| HIMS | NDAQ | |
|---|---|---|
Market Cap | $7.57B | $51.96B |
Sector | Health | Financials |
52-Week High | $66.18 | $100.98 |
52-Week Low | $14.52 | $76.85 |
Enterprise Value | $7.95B | $59.02B |
Dividend Yield | — | 1.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.
The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.
Nasdaq (NDAQ) trades at $92.00, up 0.39% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $105.60. Recent earnings beats and strong profitability margins, including a net income margin of 23.03%, highlight fundamental strength. The company continues to expand its non-trading businesses and execute strategic initiatives, as noted in recent financial media coverage.
The outlook for NDAQ is positive, driven by consistent earnings performance and strategic growth in market infrastructure. Key risks include market volatility sensitivity and high valuation multiples. Investors should weigh the robust analyst support against potential macroeconomic headwinds affecting exchange volumes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Nasdaq Inc
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →
